Trial to Evaluate Diarrhoea Discontinuations at 3 Cycles in Patients With Early-stage HER2+, HR+ Breast Cancer Treated With Neratinib Plus Loperamide Versus Neratinib Dose Escalation Plus Loperamide Administered as Needed Versus Neratinib Plus Loperamide Plus Colesevelam (DIANER)
Conditions:   Early-stage Breast Cancer;   HER2 Positive Breast Cancer;   Hormone Receptor Positive Interventions:   Drug: Neratinib;   Drug: Loperamide;   Drug: Colesevelam Sponsors:   Spanish Breast Cancer Research Group;   Puma Biotechnology, Inc.;   Pierre Fabre Laboratories Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2022 Category: Research Source Type: clinical trials

Treatment of Bile Acid Malabsorption With Liraglutide
Condition:   Bile Acid Malabsorption Interventions:   Drug: Liraglutide 6 MG/ML;   Drug: Colesevelam Sponsors:   Filip Krag Knop;   Herlev and Gentofte Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 20, 2019 Category: Research Source Type: clinical trials